Replies to post #476926 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Merck should ignore NWBO and try their luck with another P1 immunology treatment in order to save money.

I'm sure they will love the outcome of DCVax-L being engaged with Nivolumab instead.